Published by Ikaba Koyi on 21st November 2017
(ShareCast News) - NetScientific, the transatlantic healthcare IP commercialisation group, has today announced that ProAxsis, its portfolio company in which it holds a 57% stake, is forecasting higher direct sales of its ProteaseTag Active Neutrophil Elastase Immunoassay.
URL: http://www.digitallook.com/dl/news/story/26731607/...